Skip to main content
Top
Published in: Inflammation 1/2015

01-02-2015

Systemic and Flap Inflammatory Response Associates with Thrombosis in Flap Venous Crisis

Authors: Wei Du, Pan-Feng Wu, Li-Ming Qing, Cong-Yang Wang, Jie-Yu Liang, Fang Yu, Ju-Yu Tang

Published in: Inflammation | Issue 1/2015

Login to get access

ABSTRACT

Venous crisis represents the most common complication in flap surgery and often results in flap failure. The gold standard for free flap monitoring is frequent clinical examination. The current study examined the systemic inflammatory response during the immediate post-operative period following flap venous crisis. Superficial epigastric artery perforator flap transplantation was performed in a total of 30 rabbits. Fifteen animals received venous obstruction by vein ligation (venous crisis group, n = 15) and others were sham treated (control group, n = 15). Venous thrombosis was examined by immunohistochemistry staining. Plasma levels of inflammatory response markers (IL-6, IL-8, TNF-α, and C-reactive protein) and thrombosis biomarkers (von Willebrand factor and tissue factor) were measured at 0, 2, and 4 h post-operation by enzyme-linked immunosorbent assay. The mRNA levels of relevant biomarkers in the flap were analyzed with quantitative real-time PCR. Flap histopathological examination showed erythrocyte and neutrophil aggregations in venous lumen and erythrocyte diapedesis. At 8 h post-operation, serious edema and fibrinoid necrosis were observed and the venous lumen was almost blocked by thrombus. The venous crisis group had higher plasma levels of IL-8, TNF-α, and thrombosis biomarkers. Vein ligation also increased the mRNA levels of IL-8, TNF-α, C-reactive protein, von Willebrand factor, and tissue factor in the flap. No significant change in IL-6 levels was observed between the control group and the venous crisis group. Flap venous crisis was accompanied by the increase in a number of inflammatory and thrombosis markers, both in the peripheral blood and the flaps.
Literature
1.
go back to reference Geddes, C.R., S.F. Morris, and P.C. Neligan. 2003. Perforator flaps: evolution, classification, and applications. Annals of Plastic Surgery 50: 90–99.CrossRefPubMed Geddes, C.R., S.F. Morris, and P.C. Neligan. 2003. Perforator flaps: evolution, classification, and applications. Annals of Plastic Surgery 50: 90–99.CrossRefPubMed
2.
go back to reference Lee, B.T., A. Matsui, M. Hutteman, S.J. Lin, J.H. Winer, et al. 2010. Intraoperative near-infrared fluorescence imaging in perforator flap reconstruction: current research and early clinical experience. Journal of Reconstructive Microsurgery 26: 59–65.CrossRefPubMedCentralPubMed Lee, B.T., A. Matsui, M. Hutteman, S.J. Lin, J.H. Winer, et al. 2010. Intraoperative near-infrared fluorescence imaging in perforator flap reconstruction: current research and early clinical experience. Journal of Reconstructive Microsurgery 26: 59–65.CrossRefPubMedCentralPubMed
3.
go back to reference Nguyen, G.K., B.H. Hwang, Y. Zhang, J.F. Monahan, G.B. Davis, et al. 2013. Novel biomarkers of arterial and venous ischemia in microvascular flaps. PLoS One 8: e71628.CrossRefPubMedCentralPubMed Nguyen, G.K., B.H. Hwang, Y. Zhang, J.F. Monahan, G.B. Davis, et al. 2013. Novel biomarkers of arterial and venous ischemia in microvascular flaps. PLoS One 8: e71628.CrossRefPubMedCentralPubMed
4.
go back to reference Angrigiani, C., D. Grilli, and J. Siebert. 1995. Latissimus dorsi musculocutaneous flap without muscle. Plastic and Reconstructive Surgery 96: 1608–1614.CrossRefPubMed Angrigiani, C., D. Grilli, and J. Siebert. 1995. Latissimus dorsi musculocutaneous flap without muscle. Plastic and Reconstructive Surgery 96: 1608–1614.CrossRefPubMed
5.
go back to reference May Jr., J.W., L.A. Chait, B.M. O Brien, and J.V. Hurley. 1978. The no-reflow phenomenon in experimental free flaps. Plastic and Reconstructive Surgery 61: 256–267. May Jr., J.W., L.A. Chait, B.M. O Brien, and J.V. Hurley. 1978. The no-reflow phenomenon in experimental free flaps. Plastic and Reconstructive Surgery 61: 256–267.
6.
go back to reference Hjortdal, V.E., T. Sinclair, C.L. Kerrigan, and S. Solymoss. 1994. Venous ischemia in skin flaps: microcirculatory intravascular thrombosis. Plastic and Reconstructive Surgery 93: 366–374.CrossRefPubMed Hjortdal, V.E., T. Sinclair, C.L. Kerrigan, and S. Solymoss. 1994. Venous ischemia in skin flaps: microcirculatory intravascular thrombosis. Plastic and Reconstructive Surgery 93: 366–374.CrossRefPubMed
7.
go back to reference Libby, P., and D.I. Simon. 2001. Inflammation and thrombosis: the clot thickens. Circulation 103: 1718–1720.CrossRefPubMed Libby, P., and D.I. Simon. 2001. Inflammation and thrombosis: the clot thickens. Circulation 103: 1718–1720.CrossRefPubMed
8.
go back to reference Harashina, T.S.Y., and S. Watanabe. 1977. The relationship between venous occlusion time in island flaps and flap survivals. Plastic and Reconstructive Surgery 60: 92–95.CrossRefPubMed Harashina, T.S.Y., and S. Watanabe. 1977. The relationship between venous occlusion time in island flaps and flap survivals. Plastic and Reconstructive Surgery 60: 92–95.CrossRefPubMed
9.
go back to reference Strukova, S. 2006. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Frontiers in Bioscience 11: 59–80.CrossRefPubMed Strukova, S. 2006. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Frontiers in Bioscience 11: 59–80.CrossRefPubMed
10.
go back to reference Heemskerk, J.W., E.M. Bevers, and T. Lindhout. 2002. Platelet activation and blood coagulation. Thrombosis and Haemostasis 88: 186–193.PubMed Heemskerk, J.W., E.M. Bevers, and T. Lindhout. 2002. Platelet activation and blood coagulation. Thrombosis and Haemostasis 88: 186–193.PubMed
11.
go back to reference Japp, A.G., R. Chelliah, L. Tattersall, N.N. Lang, X. Meng, et al. 2013. Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans. Journal of the American Heart Association 2: e006007.CrossRefPubMedCentralPubMed Japp, A.G., R. Chelliah, L. Tattersall, N.N. Lang, X. Meng, et al. 2013. Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans. Journal of the American Heart Association 2: e006007.CrossRefPubMedCentralPubMed
12.
go back to reference Harding, S.A., A.J. Sommerfield, J. Sarma, P.J. Twomey, D.E. Newby, et al. 2004. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176: 321–325.CrossRefPubMed Harding, S.A., A.J. Sommerfield, J. Sarma, P.J. Twomey, D.E. Newby, et al. 2004. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176: 321–325.CrossRefPubMed
13.
go back to reference Ni, H., C.V. Denis, S. Subbarao, J.L. Degen, T.N. Sato, et al. 2000. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. Journal of Clinical Investigation 106: 385–392.CrossRefPubMedCentralPubMed Ni, H., C.V. Denis, S. Subbarao, J.L. Degen, T.N. Sato, et al. 2000. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. Journal of Clinical Investigation 106: 385–392.CrossRefPubMedCentralPubMed
14.
go back to reference Westein, E., A.D. van der Meer, M.J. Kuijpers, J.P. Frimat, A. van den Berg, et al. 2013. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 110: 1357–1362.CrossRefPubMedCentralPubMed Westein, E., A.D. van der Meer, M.J. Kuijpers, J.P. Frimat, A. van den Berg, et al. 2013. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 110: 1357–1362.CrossRefPubMedCentralPubMed
15.
go back to reference Groot, E., P.G. de Groot, R. Fijnheer, and P.J. Lenting. 2007. The presence of active von Willebrand factor under various pathological conditions. Current Opinion in Hematology 14: 284–289.CrossRefPubMed Groot, E., P.G. de Groot, R. Fijnheer, and P.J. Lenting. 2007. The presence of active von Willebrand factor under various pathological conditions. Current Opinion in Hematology 14: 284–289.CrossRefPubMed
16.
go back to reference Kaya, B., B. Sana, C. Eris, K. Karabulut, O. Bat, et al. 2012. The diagnostic value of D-dimer, procalcitonin and CRP in acute appendicitis. International Journal of Medical Sciences 9: 909–915.CrossRefPubMedCentralPubMed Kaya, B., B. Sana, C. Eris, K. Karabulut, O. Bat, et al. 2012. The diagnostic value of D-dimer, procalcitonin and CRP in acute appendicitis. International Journal of Medical Sciences 9: 909–915.CrossRefPubMedCentralPubMed
17.
go back to reference Ghanavatian, S., R.A. Stein, D. Atar, L. Hole, and S. Agewall. 2011. The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction. Clinical Laboratory 57: 771–776.PubMed Ghanavatian, S., R.A. Stein, D. Atar, L. Hole, and S. Agewall. 2011. The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction. Clinical Laboratory 57: 771–776.PubMed
18.
go back to reference Yoshida, H., C.E. Yilmaz, and D.N. Granger. 2011. Role of tumor necrosis factor-alpha in the extraintestinal thrombosis associated with colonic inflammation. Inflammatory Bowel Diseases 17: 2217–2223.CrossRefPubMedCentralPubMed Yoshida, H., C.E. Yilmaz, and D.N. Granger. 2011. Role of tumor necrosis factor-alpha in the extraintestinal thrombosis associated with colonic inflammation. Inflammatory Bowel Diseases 17: 2217–2223.CrossRefPubMedCentralPubMed
19.
go back to reference Yoshida, H., and D.N. Granger. 2009. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflammatory Bowel Diseases 15: 1245–1255.CrossRefPubMedCentralPubMed Yoshida, H., and D.N. Granger. 2009. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflammatory Bowel Diseases 15: 1245–1255.CrossRefPubMedCentralPubMed
22.
go back to reference Vandendries, E.R., B.C. Furie, and B. Furie. 2004. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thrombosis and Haemostasis 92: 459–466.PubMed Vandendries, E.R., B.C. Furie, and B. Furie. 2004. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thrombosis and Haemostasis 92: 459–466.PubMed
23.
go back to reference Furie, B., and B.C. Furie. 2008. Mechanisms of thrombus formation. New England Journal of Medicine 359: 938–949.CrossRefPubMed Furie, B., and B.C. Furie. 2008. Mechanisms of thrombus formation. New England Journal of Medicine 359: 938–949.CrossRefPubMed
24.
go back to reference Wang, J.G., J.E. Geddings, M.M. Aleman, J.C. Cardenas, P. Chantrathammachart, et al. 2012. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 119: 5543–5552.CrossRefPubMedCentralPubMed Wang, J.G., J.E. Geddings, M.M. Aleman, J.C. Cardenas, P. Chantrathammachart, et al. 2012. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood 119: 5543–5552.CrossRefPubMedCentralPubMed
25.
go back to reference Han, K.H., K.H. Hong, J.H. Park, J. Ko, D.H. Kang, et al. 2004. C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 109: 2566–2571.CrossRefPubMed Han, K.H., K.H. Hong, J.H. Park, J. Ko, D.H. Kang, et al. 2004. C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 109: 2566–2571.CrossRefPubMed
26.
go back to reference Yu, Q., Y. Lin, P. Yang, Y. Wang, S. Zhao, et al. 2012. C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. Journal of Thrombosis and Thrombolysis 33: 301–307.CrossRefPubMed Yu, Q., Y. Lin, P. Yang, Y. Wang, S. Zhao, et al. 2012. C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. Journal of Thrombosis and Thrombolysis 33: 301–307.CrossRefPubMed
27.
go back to reference Winbeck, K., H. Poppert, T. Etgen, B. Conrad, and D. Sander. 2002. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33: 2459–2464.CrossRefPubMed Winbeck, K., H. Poppert, T. Etgen, B. Conrad, and D. Sander. 2002. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33: 2459–2464.CrossRefPubMed
28.
go back to reference Henke, P.K., T.W. Wakefield, A.M. Kadell, M.J. Linn, M.R. Varma, et al. 2001. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. Journal of Surgical Research 99: 84–91.CrossRefPubMed Henke, P.K., T.W. Wakefield, A.M. Kadell, M.J. Linn, M.R. Varma, et al. 2001. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. Journal of Surgical Research 99: 84–91.CrossRefPubMed
29.
go back to reference Del Ry, S., M.A. Morales, M.C. Scali, A. Tafi, C. Giustarini, et al. 2013. Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients. Clinical Laboratory 59: 843–849.PubMed Del Ry, S., M.A. Morales, M.C. Scali, A. Tafi, C. Giustarini, et al. 2013. Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients. Clinical Laboratory 59: 843–849.PubMed
30.
go back to reference Rodland, E.K., T. Ueland, S. Bjornsen, E.L. Sagen, C.P. Dahl, et al. 2012. Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis. BMC Infectious Diseases 12: 144.CrossRefPubMedCentralPubMed Rodland, E.K., T. Ueland, S. Bjornsen, E.L. Sagen, C.P. Dahl, et al. 2012. Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis. BMC Infectious Diseases 12: 144.CrossRefPubMedCentralPubMed
Metadata
Title
Systemic and Flap Inflammatory Response Associates with Thrombosis in Flap Venous Crisis
Authors
Wei Du
Pan-Feng Wu
Li-Ming Qing
Cong-Yang Wang
Jie-Yu Liang
Fang Yu
Ju-Yu Tang
Publication date
01-02-2015
Publisher
Springer US
Published in
Inflammation / Issue 1/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-0033-9

Other articles of this Issue 1/2015

Inflammation 1/2015 Go to the issue